The ongoing Ebola outbreak has reached 3,200 confirmed cases, prompting an urgent global response to contain the spread of the virus.
The UK has approved the world's first human trial for a vaccine targeting the Bundibugyo strain, a critical step in the race to develop effective treatments.
Health organizations are working to scale up vaccination efforts, as the case tally nears record levels and the risk of further regional transmission remains high.